Showing results (31-40 of 52) with videos related to
Sort By:
Pageof 6
Hepatology (Baltimore, Md.)|December 31, 2008
Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1-hepatitis B virus coinfected individuals: similar effectiveness of lamivudine, tenofovir, or combination therapySharon R Lewin, Ruy M Ribeiro, Anchalee Avihingsanon, et al.Hepatology (Baltimore, Md.)|October 10, 2007
The phenotype of hepatitis B virus-specific T cells differ in the liver and blood in chronic hepatitis B virus infectionJ Judy Chang, Alexander J V Thompson, Kumar Visvanathan, et al.AIDS (London, England)|November 16, 2010
Increased intrahepatic apoptosis but reduced immune activation in HIV-HBV co-infected patients with advanced immunosuppressionDavid M Iser, Anchalee Avihingsanon, Naruemon Wisedopas, et al.Liver International : Official Journal of the International Association for the Study of the Liver|March 14, 2018
Mother-to-child transmission of hepatitis B: Examining viral cut-offs, maternal HBsAg serology and infant testingCynthuja Thilakanathan, Gabrielle Wark, Michael Maley, et al.The Medical Journal of Australia|May 6, 2009
Perinatal transmission of hepatitis B virus: an Australian experienceElke Wiseman, Melissa A Fraser, Sally Holden, et al.Journal of Hepatology|May 8, 2014
Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virusAstrid-Jane Greenup, Pok Kern Tan, Vi Nguyen, et al.Nature Reviews. Disease Primers|June 8, 2018
Hepatitis B virus infectionMan-Fung Yuen, Ding-Shinn Chen, Geoffrey M Dusheiko, et al.AIDS (London, England)|August 11, 2007
Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individualsPeter A Revill, Margaret Littlejohn, Anna Ayres, et al.Antiviral Research|July 2, 2015
Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intentRobert G Gish, Man-Fung Yuen, Henry Lik Yuen Chan, et al.Journal of Virology|April 2, 2010
Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigenDavid M Iser, Nadia Warner, Peter A Revill, et al.Pageof 6